BofA cuts American Express stock price target on updated estimates By Investing.com

BofA set a new price target of $381 for American Express (from $382), implying ~28% upside to the current $298.39 share price; shares are down 18.7% YTD. February U.S. consumer card loans fell to $95.1B from $97.2B in January, delinquency held steady at 1.4% and net write-offs ticked up to 2.0% from 1.9%. BofA slightly tweaked EPS estimates (Q1'26 $4.00 vs $3.93 prior; FY26 $17.48 vs $17.51 prior; 2027 $20.04 vs $20.08) and applies a 19x multiple to 2027 EPS; analyst views remain mixed with RBC Outperform PT $425 and BTIG Sell PT $285.

Analysis

American Express’s franchise is being underwritten by structural advantages (closed-loop data, affluent customer mix, and premium fee income) that mute cyclical credit volatility but amplify sensitivity to shifts in discretionary spend. The market often misprices that asymmetry: credit shocks bite with a lag through charge-off roll rates and seasonality, while revenue recovery from travel and corporate spend can re-accelerate within two to three quarters once consumer confidence rebounds.

Near-term catalysts are dominated by central bank action and real-time payment flows. Rate moves over days-to-weeks will mechanically reprice funding and yield on receivables, while weekly card-spend prints and payroll data over the next 4–12 weeks will reveal whether the current resilience is durable or already deteriorating into higher loss formation.

Second-order winners if AmEx outperforms include high-margin travel suppliers and loyalty/merchant partners that rely on affluent cohorts; losers include lower-card-margin fintech lenders and subprime-focused issuers whose loss rates are more elastic to an income shock. Regulatory or merchant-fee interventions remain a latent tail risk that could compress economics faster than credit deterioration in a downturn.

Key Decisions for Investors

• Long AXP vs short COF (pair trade), 12–18 month horizon: overweight AXP by 1.0–1.5% of NAV and short Capital One equal notional to express idiosyncratic resilience of a premium card franchise versus scale-driven unsecured lenders. Target asymmetric return of ~25% upside on the long leg vs ~12–15% downside; stop-loss if spread widens >25% intramonth.
• Buy AXP 9-month call spread (debit): use a 1:1 long-call / short-higher-strike structure to cap premium while keeping 2:1 upside-to-cost profile if travel/corporate spend normalizes. Size to 0.5–1.0% of NAV and roll or unwind after next two monthly spend prints if macro softens.
• Short a 6–12 month basket of subprime card names (e.g., select regional issuers), hedge with 30–40% notch long exposure in investment-grade bank equities (BAC), to capture divergence between prime/premium and subprime credit cycles. Risk: correlation can spike in systemic stress—cap position to 2% NAV and monitor weekly loss-rate prints.
• Maintain a 6–12 month tail hedge: buy broad consumer-credit put protection (index puts or options on a consumer-bank ETF) sized to offset potential 15–25% portfolio drawdown from a rapid credit deterioration shock following a labor-market surprise.